We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTR icon
1126
Avantor
AVTR
$9.28B
$378K 0.01%
+9,234
New +$361K
EPIX
1127
DELISTED
ESSA Pharma
EPIX
$378K 0.01%
+47,300
New +$752K
DLN icon
1128
WisdomTree US LargeCap Dividend Fund
DLN
$6.25B
$377K 0.01%
6,324
-7,706
-55% -$475K
TFLO icon
1129
iShares Treasury Floating Rate Bond ETF
TFLO
$6.54B
$377K 0.01%
7,492
SDHY
1130
PGIM Short Duration High Yield Opportunities Fund
SDHY
$397M
$375K 0.01%
20,000
RVP icon
1131
Retractable Technologies
RVP
$19.8M
$374K 0.01%
33,940
-9,119
-21% -$107K
SONO icon
1132
Sonos
SONO
$1.73B
$373K 0.01%
11,535
-400
-3% -$14.4K
CURI icon
1133
CuriosityStream
CURI
$143M
$372K 0.01%
35,335
+1,230
+4% +$14.5K
NMFC icon
1134
New Mountain Finance
NMFC
$648M
$372K 0.01%
27,943
+178
+0.6% +$2.38K
AZEK
1135
DELISTED
The AZEK Co
AZEK
$367K 0.01%
10,051
SRPT icon
1136
Sarepta Therapeutics
SRPT
$1.6B
$367K 0.01%
3,972
-90
-2% -$6.93K
EWBC icon
1137
East-West Bancorp
EWBC
$17.9B
$364K 0.01%
4,700
PMO
1138
Franklin Municipal Opportunities Trust
PMO
$280M
$363K 0.01%
26,530
LECO icon
1139
Lincoln Electric
LECO
$14.3B
$362K 0.01%
+2,807
New +$382K
SCHP icon
1140
Schwab US TIPS ETF
SCHP
$16.3B
$362K 0.01%
+11,564
New +$365K
VDE icon
1141
Vanguard Energy ETF
VDE
$10B
$362K 0.01%
4,894
+1,957
+67% +$136K
MBT
1142
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$362K 0.01%
37,599
+15,769
+72% +$142K
PCG icon
1143
PG&E
PCG
$38.5B
$361K 0.01%
+37,596
New +$355K
BTX
1144
BlackRock Technology and Private Equity Term Trust
BTX
$949M
$360K 0.01%
19,879
+9,044
+83% +$176K
MRTX
1145
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$360K 0.01%
2,035
P
1146
Everpure Inc
P
$25.8B
$359K 0.01%
14,250
FTV icon
1147
Fortive
FTV
$17.9B
$356K 0.01%
6,692
-110
-2% -$6.02K
TAP icon
1148
Molson Coors Class B
TAP
$7.76B
$356K 0.01%
7,677
+915
+14% +$44.7K
VYMI icon
1149
Vanguard International High Dividend Yield ETF
VYMI
$20.6B
$356K 0.01%
5,392
+570
+12% +$38.6K
NWE icon
1150
NorthWestern Energy
NWE
$4.24B
$355K 0.01%
6,200

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.